Scars
52
6
8
28
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.7%
4 terminated out of 52 trials
87.5%
+1.0% vs benchmark
12%
6 trials in Phase 3/4
18%
5 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (52)
Laser Treatment for the Improvement of Scars and Scleroderma
A Clinical Study Testing How Well the Medical Device HTIC (a Type of Animal-derived Collagen) Works in Treating Skin Problems, Such as Scars, Loss of Firmness, and Volume in Certain Areas of the Face and Body
Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
PMCF Investigation of Medical Device ChitoCare® Medical
Silicone vs Pirfenidone in the Treatment of Hypertrophic Scars and Keloids
AVAVA MIRIA General Use
AV-23-001 AVAVA MIRIA Pilot Study
Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
Autologous Nanofat Grafting by Injection Versus With Microneedling in Post-burn and Traumatic Atrophic Scars
Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
Treatment of Hypopigmented Scars With Bimatoprost
Post-surgical Scars After the Use of CACIPLIQ20
Study of a Novel Microlens Array Device for Skin Rejuvenation
Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance
Optical Clearing of the Skin in Conjunction With Laser Treatments
Treatment of Breast Lift/Reduction Scars
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
Evaluation of the 755nm Alexandrite Laser for the Treatment of Scars
Clinical Study to Evaluate the Safety and Effectiveness of the Treatment With Tixel C on Acne Scars